Clincosm LogoSign in Get a demo

carcinoma, squamous

Showing 1 - 7 of 7
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Tumors, Carcinoma, Squamous, Antineoplastic Agents Trial (Nivolumab Injection [Opdivo])

Not yet recruiting
  • Neoplasms
  • +2 more
  • Nivolumab Injection [Opdivo]
  • (no location specified)
Jul 19, 2023

Progression of Invasive Squamous Cell Carcinoma

Recruiting
  • Carcinoma, Squamous Cell
  • +10 more
  • DNA Extraction
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Sep 27, 2022

HER2-positive, Adenocarcinoma, Bile Duct Cancer Trial in United States (CT-0508)

Recruiting
  • HER2-positive
  • +30 more
  • CT-0508
  • Duarte, California
  • +4 more
Feb 1, 2022

Carcinoma, Squamous, Head Neck Cancer, Oral Cancer Trial run by the NCI (Bortezomib (Velcade, PS-341), Cetuximab, Cisplatin)

Completed
  • Carcinoma, Squamous
  • +4 more
  • Bortezomib (Velcade, PS-341)
  • +3 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Dec 14, 2019

Carcinoma, Squamous, Squamous Cell Carcinoma, Oropharyngeal Tumors Trial (cisplatin, Cetuximab, BYL719)

Withdrawn
  • Carcinoma, Squamous
  • +3 more
  • (no location specified)
Nov 8, 2017

Head Neck Cancer, Carcinoma, Squamous Trial in Kansas City (Oxaliplatin, Docetaxel, Cetuximab)

Terminated
Has Results
  • Head and Neck Cancer
  • Carcinoma, Squamous
  • Kansas City, Kansas
    University of Kansas Medical Center
May 16, 2017

NSCLC, Carcinoma, Squamous, Carcinoma, Large Cell Trial in Korea, Republic of (Docetaxel, Oxaliplatin)

Unknown status
  • Carcinoma, Non-Small-Cell Lung
  • +2 more
  • Cheonan, Korea, Republic of
  • +4 more
Dec 19, 2011